Dr. Yogesh Gawale, MBBS, MD, FANMB, is a highly skilled and board-certified Nuclear Medicine Physician with a specialization in molecular diagnostics and theranostics. As a Consultant in Nuclear Medicine at Cancer Centers of America (CCA) Nashik, Dr. Gawale brings extensive expertise in PET/CT and SPECT/CT imaging and reporting for oncology and non-oncology cases. His training at Tata Memorial Hospital, Mumbai, a premier institution in cancer care, has equipped him with in-depth knowledge and proficiency in advanced nuclear medicine techniques.

 

Dr. Gawale's expertise includes radionuclide therapies such as Lu-177 DOTATATE PRRT and Ac-225 DOTATATE for metastatic neuroendocrine tumors, as well as Lu-177 PSMA and Ac-225 PSMA for metastatic prostate cancer. These cutting-edge treatments have positioned him as a leader in delivering precise and effective care to cancer patients. His work in molecular imaging has been instrumental in enhancing diagnostic accuracy and improving patient outcomes through the use of advanced PET tracers, including FDG, PSMA, NOTA, and DOPA.

 

A dedicated professional, Dr. Gawale has also contributed to the academic and research community. His oral presentation on the prognostic significance of baseline 18F-FDG PET/CT parameters in patients with multiple myeloma at SNMICON India 2021 reflects his commitment to advancing nuclear medicine and its role in oncology. Additionally, his fellowship from the Asian Board of Nuclear Medicine (2024) underscores his pursuit of excellence in this evolving field.

 

With a focus on personalized care and a commitment to innovation, Dr. Yogesh Gawale plays a pivotal role at Cancer Centers of America Nashik, ensuring that patients receive state-of-the-art diagnostic and therapeutic services tailored to their unique needs. His dedication to staying at the forefront of nuclear medicine aligns seamlessly with CCA's mission to provide world-class, compassionate cancer care.